-
Mashup Score: 2Stanford ends year with leadership uncertainty - 11 month(s) ago
One of America’s premier research institutions ends an academic year with both of its top leadership positions in question, waiting on an unprecedented misconduct investigation into the University’s own president.
Source: The Stanford DailyCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 96Jay Bhattacharya joins DeSantis’ presidential bid kickoff - 11 month(s) ago
Stanford professor Jay Bhattacharya joined the live Twitter Space where Florida governor Ron De Santis announced his 2024 presidential bid, asking him questions about plans to reform public health and federal agencies. Bhattacharya has previously praised DeSantis on how he had dealt with COVID-19 restrictions.
Source: The Stanford DailyCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 94Jay Bhattacharya joins DeSantis’ presidential bid kickoff - 11 month(s) ago
Stanford professor Jay Bhattacharya joined the live Twitter Space where Florida governor Ron De Santis announced his 2024 presidential bid, asking him questions about plans to reform public health and federal agencies. Bhattacharya has previously praised DeSantis on how he had dealt with COVID-19 restrictions.
Source: The Stanford DailyCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 84Jay Bhattacharya joins DeSantis’ presidential bid kickoff - 11 month(s) ago
Stanford professor Jay Bhattacharya joined the live Twitter Space where Florida governor Ron De Santis announced his 2024 presidential bid, asking him questions about plans to reform public health and federal agencies. Bhattacharya has previously praised DeSantis on how he had dealt with COVID-19 restrictions.
Source: The Stanford DailyCategories: Emergency Medicine, Latest HeadlinesTweet
-
Mashup Score: 34Jay Bhattacharya joins DeSantis’ presidential bid kickoff - 11 month(s) ago
Stanford professor Jay Bhattacharya joined the live Twitter Space where Florida governor Ron De Santis announced his 2024 presidential bid, asking him questions about plans to reform public health and federal agencies. Bhattacharya has previously praised DeSantis on how he had dealt with COVID-19 restrictions.
Source: The Stanford DailyCategories: Infectious Disease, Latest HeadlinesTweet
-
Mashup Score: 0Editorial Board | What does Stanford stand for? - 1 year(s) ago
In its inaugural article, the Editorial Board of Volume 263 urges Stanford to condemn its fraudulent alumni and initiate campus conversations around ethical abuses as they happen. “If Stanford refuses to acknowledge the wrongdoings of its recent graduates, the university is denying its role in shaping leaders who have harmed people’s lives and livelihoods,” the Board writes.
Source: The Stanford DailyCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 0
His paper was called “the miracle result.” But it never turned into an Alzheimer’s treatment. Now, four former Genentech senior scientists and executives allege that an internal review in 2011 discovered the paper had been based on fabricated research — and that Marc Tessier-Lavigne kept the results of the review from becoming public. He denies the allegations.
Source: The Stanford DailyCategories: Expert Picks, Latest HeadlinesTweet
-
Mashup Score: 8
His paper was called “the miracle result.” But it never turned into an Alzheimer’s treatment. Now, four former Genentech senior scientists and executives allege that an internal review in 2011 discovered the paper had been based on fabricated research — and that Marc Tessier-Lavigne kept the results of the review from becoming public. He denies the allegations.
Source: The Stanford DailyCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 0
His paper was called “the miracle result.” But it never turned into an Alzheimer’s treatment. Now, four former Genentech senior scientists and executives allege that an internal review in 2011 discovered the paper had been based on fabricated research — and that Marc Tessier-Lavigne kept the results of the review from becoming public. He denies the allegations.
Source: The Stanford DailyCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0
His paper was called “the miracle result.” But it never turned into an Alzheimer’s treatment. Now, four former Genentech senior scientists and executives allege that an internal review in 2011 discovered the paper had been based on fabricated research — and that Marc Tessier-Lavigne kept the results of the review from becoming public. He denies the allegations.
Source: The Stanford DailyCategories: Hem/Oncs, Latest HeadlinesTweet
Stanford ends academic year with leadership uncertainty. @StanfordDaily @Stanford https://t.co/JqRLUk3RYA